Valuation: Divi's Laboratories Limited

Market Cap 2,96000Cr 3.15TCr 2.86TCr 2.65TCr 2.39TCr 4.51TCr 4.67TCr 32TCr 13TCr 1,58800Cr 12TCr 12TCr 5,03100Cr P/E 2027 *
74.8x
P/E 2028 * 65.4x
Enterprise Value 2,92400Cr 3.11TCr 2.83TCr 2.61TCr 2.36TCr 4.46TCr 4.61TCr 31TCr 12TCr 1,56900Cr 12TCr 11TCr 4,97000Cr EV / Sales 2027 *
21.2x
EV / Sales 2028 * 17.7x
Free-Float
48%
Yield 2027 *
0.33%
Yield 2028 * 0.37%
1 day+0.63%
1 week-3.59%
Current month+14.01%
1 month+21.93%
3 months+31.53%
6 months+64.93%
Current year+74.42%
1 week 10,954
Extreme 10954
11,800.5
1 month 8,797
Extreme 8797
11,824
Current year 5,647.5
Extreme 5647.5
11,824
1 year 5,647.5
Extreme 5647.5
11,824
3 years 3,350
Extreme 3350
11,824
5 years 2,730
Extreme 2730
11,824
10 years 532.65
Extreme 532.65
11,824
Manager TitleAgeSince
Chief Executive Officer 75 26/11/2009
Chief Executive Officer 49 04/01/2020
Director of Finance/CFO 65 01/08/2025
Director TitleAgeSince
Director/Board Member 49 26/11/2009
Chairman 75 26/11/2009
Director/Board Member 68 01/10/1994
Date Insider Type Main position Quantity % Market Cap. Importance
26/03/25 Sell

Executive/Senior Manager

25,000 0.0094%
15/03/25 Sell 300 0.0001%
17/02/25 Sell 500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+0.63%-3.59%+71.24%+214.24% 3.13TCr
-1.08%-1.55%+38.02%+138.31% 1,27500Cr
-0.67%-0.26%+40.32%+86.96% 68TCr
-0.41%-0.40%+25.09%+111.64% 52TCr
-0.76%+1.10%+41.43%+70.96% 39TCr
-0.33%-3.10%+54.50%+41.00% 36TCr
-1.83%-0.89%+26.00%+58.48% 31TCr
-1.65%-0.59%+1.55%+34.52% 29TCr
-0.63%-1.67%+33.87%+72.37% 25TCr
+1.47%-0.82%+36.57%+124.61% 21TCr
Average -0.65%+0.04%+36.86%+95.31% 43TCr
Weighted average by Cap. -0.88%+0.72%+35.13%+96.29%

Financials

2027 *2028 *
Net sales 14TCr 147.16Cr 133.69Cr 123.53Cr 111.58Cr 210.57Cr 217.97Cr 1.49TCr 588.59Cr 7.42TCr 552.2Cr 540.51Cr 23TCr 16TCr 175.04Cr 159.02Cr 146.93Cr 132.71Cr 250.45Cr 259.26Cr 1.77TCr 700.09Cr 8.82TCr 656.8Cr 642.91Cr 28TCr
Net income 3.95TCr 42Cr 38Cr 35Cr 32Cr 60Cr 62Cr 424.87Cr 168.34Cr 2.12TCr 157.93Cr 154.59Cr 6.72TCr 4.48TCr 48Cr 43Cr 40Cr 36Cr 68Cr 71Cr 481.77Cr 190.89Cr 2.4TCr 179.09Cr 175.3Cr 7.62TCr
Net Debt -3.64TCr -39Cr -35Cr -33Cr -29Cr -55Cr -57Cr -391.15Cr -154.98Cr -1.95TCr -145.4Cr -142.32Cr -6.18TCr -4.97TCr -53Cr -48Cr -44Cr -40Cr -76Cr -78Cr -534.27Cr -211.69Cr -2.67TCr -198.6Cr -194.4Cr -8.45TCr
Projected Income Statement - Annual - Divi's Laboratories Limited
Logo Divi's Laboratories Limited
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.
Employees
11,565
Date Price Change Volume
17/26/17 ₹11,150.00 +0.63% 7,27,653
16/26/16 ₹11,080.00 -3.16% 9,03,749
13/26/13 ₹11,442.00 -0.37% 5,36,553
12/26/12 ₹11,485.00 +1.04% 7,28,979
11/26/11 ₹11,367.00 -1.72% 16,02,464
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Divi's Laboratories Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
11,150.00INR
Average target price
11,083.11INR
Spread / Average Target
-0.60%
  1. Stock Market
  2. Stocks
  3. DIVISLAB Stock